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Major hormones influence the development, proliferation and
differentiation of the human breast (Rebar, 1994). Based primarily
on animal studies, it has been shown that mammary cells prolif-
erate in the first and second trimester of pregnancy and differen-
tiate in the last trimester (Russo and Russo, 1980). This led Russo
and Russo to hypothesize that complete differentiation of the
breast cells conveyed by a full-term pregnancy has to be achieved
to provide protection against carcinogenic effects. Earlier termina-
tion of pregnancy, on the contrary, might increase the risk of breast
cancer because proliferation of the breast cells will take place
without subsequent differentiation (Russo and Russo, 1980).
Breast cancer risk in women with a history of a short-term preg-
nancy has primarily been investigated in relation to spontaneous
and induced abortions (Kvåle et al, 1987; Adami et al, 1990;
Daling et al, 1994; Calle et al, 1995; Michels et al, 1995;
Newcomb et al, 1996; Melbye et al, 1997) that occur during the
early period of pregnancy. In particular, large prospective studies
have not found such women to be at increased risk of breast cancer
(Kvåle et al, 1987; Calle et al, 1995; Melbye et al, 1997). In
contrast, few studies have addressed the late period of pregnancy
and whether a preterm delivery is associated with an increased risk
of breast cancer (Choi et al, 1978; Polednak and Janerich, 1983).
In the present study we took advantage of the long tradition
for mandatory reporting of pregnancy characteristics and cancer
diagnoses in Denmark to address in a prospective study whether
women with preterm delivery are at increased risk of breast cancer
compared to other women.
MATERIAL AND METHODS
Registries
We performed a linkage of data from the Danish Civil Registration
System (CRS) with the National Birth Registry, the National
Hospital Discharge Registry, the National Registry of Induced
Abortions and the Danish Cancer Registry. Since April 1968, the
CRS has assigned a unique identification number to all residents in
Denmark which permits accurate linkage of information from
different registries. The CRS also keeps updated information on
dates of live births and documents demographic information such
as emigration and death.
Since 1973 the National Birth Registry has registered all live-
births and stillbirths in Denmark (not including spontaneous and
induced abortions). Since 1978, exact (in weeks) gestational age
determinations have been included. Gestational age determination
is based on information of last menstrual period combined with an
early clinical bimanual palpation. In situations of inconsistency
between these measures, ultrasound scanning is performed. In the
most recent years the use of ultrasound scanning has become
widespread and has as such contributed increasingly to the deter-
minations of the gestational age (Sundhedsstyrelsen, 1993). Since
1977, information on spontaneous abortions without specified
gestational age has been recorded in the National Hospital
Discharge Registry. Information on induced abortions has been
recorded in the National Registry of Induced Abortions since
reporting became mandatory in 1939. However, information is
only available in a computerized format since 1973 (Melbye et al,
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Summary To explore the risk of breast cancer in relation to the length of a pregnancy we tested whether a preterm delivery carries a higher
risk of breast cancer than does a full-term delivery. Based on information from the Civil Registration System, and the National Birth Registry
in Denmark, we established a population-based cohort of 474 156 women born since April 1935, with vital status and detailed parity
information, including the gestational age of liveborn children and stillbirths. Information on spontaneous and induced abortions was obtained
from the National Hospital Discharge Registry and the National Registry of Induced Abortions. Incident cases of breast cancer in the cohort
(n = 1363) were identified through linkage with the Danish Cancer Registry. The period at risk started in 1978 and continued until a breast
cancer diagnosis, death, emigration, or 31 December, 1992, whichever occurred first. After adjusting for attained age, parity, age at first
birth and calendar period, we observed the following relative risks of breast cancer for different lengths of the pregnancy: < 29 gestational
weeks = 2.11 (95% confidence interval 1.00–4.45); 29–31 weeks = 2.08 (1.20–3.60); 32–33 weeks = 1.12 (0.62–2.04); 34–35 weeks = 1.08
(0.71–1.66); 36–37 weeks = 1.04 (0.83–1.32); 38–39 weeks = 1.02 (0.89–1.17); 40 weeks = 1 (reference). Parous women who had a
preterm delivery below 32 weeks gestation had a 1.72-fold (1.14–2.59) increased risk of breast cancer compared with other parous women.
In conclusion, a preterm delivery of 32+ weeks gestation did not significantly increase a woman’s risk of contracting breast cancer. Only for
the very small group of women with preterm deliveries of less than 32 weeks gestation did we observe an increased risk.
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Subjects
A research database was established from the CRS including all
women born in Denmark between 1 April 1935 and 31 March
1978, with information on live-born children. From the National
Birth Registry additional information on stillbirths was added as
was gestational age-specific information on all births since 1978.
Finally, information on spontaneous (since 1977) and induced
abortions (since 1973) was added.
Analyses
The possible impact of gestational age at delivery (preterm, or term
delivery) on the risk of breast cancer was investigated among
parous women in a log-linear Poisson regression model (Breslow
and Day, 1987). All women entered the follow-up for breast cancer
at the first delivery they had during the period between 1 January
1978 and 31 December 1992, in which gestational age was
recorded. Thus, women with pregnancies before 1 January 1978
were included in the study provided they had a delivery during the
study period. The period at risk continued until breast cancer diag-
nosis, death, emigration, disappearance, or 31 December 1992 (at
which time the cancer registration was considered complete),
whichever occurred first. Person-years at risk were calculated
continuously according to the categorical groups of gestational age
of the most recent birth in the years 1978–1992, i.e. women with
more than one birth between 1978 and 1992 were considered at
risk in the period between the first and second birth, according to
the gestational age of the first birth; between the second and third
birth, according to the gestational age of the second birth; and so
on. To evaluate the effect of ever having a preterm delivery, an
additional analysis was performed where person-years at risk were
calculated continuously in categorical groups according to the birth
with the lowest gestational age since 1978. Adjustments were
made for attained age (1-year intervals), calendar period (5-year
intervals), age at first birth (12–19, 20–24, 25–29, 30–34, > 34
years) and parity (1, 2, 3, 4, 5, 6, ³ 7 births; including stillbirths,
preterm and term deliveries). In an additional analysis we adjusted
for history of spontaneous and induced abortion and whether the
birth was a stillbirth or a multiple birth. Note that information on
history of spontaneous and induced abortions, stillbirths and live-
births prior to 1 January 1978 was also used in the adjustment.
Estimation of breast cancer incidence rate ratios was performed
using the SAS procedure PROC GENMOD (SAS Institute, 1996).
These rate ratios were used as a measure of the relative risk (RR).
Test for trend was performed with gestational age treated as a
continuous variable and the median gestational age used as the
value for each group. The linear assumption in the trend test was
checked by a likelihood ratio test against the model with gesta-
tional age as categorical variable. Effect modification was evalu-
ated as a test for interaction between categorical variables.
To assess the possible effect of misclassification due to unregis-
tered gestational age in births prior to 1978 we estimated the
percentage of person-years of follow-up and the number of cases
in each cell that might be attributed to the ‘ever had a delivery with
a gestational age less than 32 weeks’ category, instead of the
‘never’ category, and then performed the analysis with the
adjusted figures. The percentage of person-years was calculated
on the basis of the age-specific cumulative incidence at the base-
line of the study, and the number of cases was calculated as the
product of the estimated person-years and the rate in the ever cate-
gory found in the original analysis. The age-specific cumulative
incidence of having a delivery with a gestational age less than 32
weeks was calculated using age-specific incidence rates seen in
1983–1992.
RESULTS
Overall, 474 156 parous women were included in the cohort study.
In the follow-up a total of 740 794 births were recorded and
distributed as follows: 254 458 women (53.7%) had one birth,
178 700 women (37.7%) had two, 35 791 women (7.5%) had three
and 5207 women (1.1%) had four or more births. Among these
births, 3261 were stillbirths (0.4%) and 37 347 (5.0%) were
preterm (< 37 gestational weeks). Preterm births with a gestational
age of 32–36 weeks contributed 4.2%, with a gestational age of
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Table 1 Distribution of number of breast cancer diagnoses and person-
years of follow-up according to age and reproductive history
preterm delivery Full-term delivery
No. of Person- No. of Person
cases (%) years (%) cases (%) years (%)
(´ 103)( ´ 103)
Age (years)
< 35 16 (20) 127 (69) 315 (25) 2507 (70)
35–39 31 (38) 35 (19) 417 (32) 714 (20)
40–44 24 (30) 16 (9) 379 (30) 299 (8)
45–49 8 (10) 5 (3) 147 (11) 72 (2)
50+ 2 (2) 1 (0.4) 24 (2) 9 (0.2)
Age at first birth
(years)
< 20 9 (11) 30 (17) 93 (7) 464 (13)
20–24 24 (30) 82 (45) 432 (34) 1728 (48)
25–29 27 (33) 52 (28) 501 (39) 1107 (31)
30–34 18 (22) 15 (8) 191 (25) 254 (7)
35+ 3 (4) 4 (2) 65 (5) 48 (1)
Age at latest birth
(years)
< 20 0 (0) 8 (4) 1 (0.1) 105 (3)
20–24 1 (1) 47 (26) 54 (4) 874 (24)
25–29 23 (28) 68 (37) 351 (28) 1449 (40)
30–34 29 (36) 41 (22) 513 (40) 872 (24)
35+ 28 (35) 20 (11) 363 (28) 300 (9)
Number of previous
birthsa
0 23 (28) 78 (42) 240 (19) 1281 (36)
1 31 (38) 68 (37) 611 (48) 1609 (45)
2 19 (24) 27 (15) 313 (24) 553 (15)
3+ 8 (10) 11 (6) 118 (9) 157 (4)
Previous preterm birth
or stillbirtha
Yes 5 (6) 12 (7) 17 (1) 60 (2)
No 76 (94) 171 (93) 1265 (99) 3540 (98)
The delivery was a
multiple birth
Yes 9 (11) 16 (9) 20 (2) 35 (1)
No 72 (89) 167 (91) 1262 (98) 3566 (99)
a ‘Previous’ means prior to the most recent pregnancy.29–31 weeks 0.5%, and with a gestational age of less than 29
weeks 0.3%. The number of women with a preterm delivery was
as follows: 32–36 weeks = 29 488 women; 29–31 weeks = 3702
women; < 29 weeks = 2181 women. Parous women represented a
total of 3.8 million person-years of follow-up and 1363 of these
women developed breast cancer. Table 1 presents a detailed distri-
bution of number of breast cancer diagnoses and person-years of
follow-up.
As shown in Table 2, we found a significantly increased relative
risk of breast cancer in women with a preterm delivery at < 29
gestational weeks of 2.11 (95% confidence intervals (CI)
1.00–4.45) and at 29–31 gestational weeks of 2.08 (1.20–3.60),
which subsequently dropped as follows: 32–33 weeks: RR = 1.12
(0.62–2.04); 34–35 weeks: RR = 1.08 (0.71–1.66); 36–37 weeks:
RR = 1.04 (0.83–1.32); 38–39 weeks: RR = 1.02 (0.89–1.17),
40 weeks: 1 (reference). The continued decline in RR observed for
preterm deliveries was statistically significant (P-trend = 0.04).
The trend remained significant after adjustment for history of
spontaneous abortion, history of induced abortion, and whether the
birth was a stillbirth and/or a multiple birth (P-trend = 0.04).
A stratified analysis, which was performed to evaluate whether the
increased risk of breast cancer was associated both with preterm
livebirths and preterm stillbirths, gave the following result with
term deliveries as reference: life births with gestational age
< 32 weeks: RR = 1.98 (1.24–3.16); stillbirths with gestational
age < 32 weeks: RR = 4.62 (0.42–50.9).
The possible effect modification by age of the woman, number
of previous births, age at delivery and history of previous preterm
births or stillbirths is evaluated in Table 3. None of these charac-
teristics significantly modified the risk association observed with
gestational age. However, the number of cases in some of the strat-
ified subgroups became very small. We evaluated whether possible
temporal changes in the validity and completeness of the ascertain-
ment of the gestational age had a measurable effect on the results
by testing whether there was a significant effect modification by
period of delivery. This was not the case (P = 0.62).
Comparing parous women ever having a delivery of less than
32 gestational weeks with other parous women we found a signifi-
cantly increased risk of 1.72 (1.14–2.59). When we considered
only parous women ever having a delivery less than 32 weeks’
gestation, but with the most recent delivery being equal to or
longer than 32 weeks’ gestation, we found no increased risk when
comparing with parous women who had never had a delivery of
less than 32 gestational weeks (RR = 0.82; 95% CI: 0.26–2.55).
However, this result was based on only three cases of breast cancer
in this particular group of women.
Based on the age-specific incidence rates of births with a gesta-
tional age less than 32 weeks we estimated that less than 2% will
ever experience such a delivery. Taking that into account at the
baseline of the analysis the rate ratio between parous women ever
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Table 2 Adjusteda relative risk of breast cancer in 474 156 parous women
according to gestational age at delivery
Gestational No. of cases Person-years RR (95% CI)
age (weeks) (´ 103)
< 29 7 9 2.11 (1.00–4.45)
29–31 13 17 2.08 (1.20–3.60)
32–33 11 26 1.12 (0.62–2.04)
34–35 22 58 1.08 (0.71–1.66)
36–37 82 214 1.04 (0.83–1.32)
38–39 350 949 1.02 (0.89–1.17)
40 552 1526 1
> 40 326 985 1.03 (0.90–1.18)
aAdjusted for age, calendar period, parity and age at first birth.
Table 3 Adjusteda relative risk of breast cancer in parous women according to gestational age at delivery by age, number of previous births, age at delivery
and history of preterm births/stillbirths
Gestational age
³ 37 weeks 36–32 weeks < 32 weeks
No. of No. of No. of
cases RR (ref.) cases RR (95% CI) cases RR (95% CI)
Age of womanb
< 40 years 732 1 37 1.21 (0.87–1.69) 10 2.00 (1.07–3.74)
³ 40 years 550 1 24 0.88 (0.58–1.32) 10 2.11 (1.13–3.95)
Number of previousc
birthsd
0 240 1 17 1.14 (0.70–1.87) 6 2.41 (1.07–5.42)
1+ 1042 1 44 1.03 (0.76–1.39) 14 1.94 (1.14–3.29)
Age at deliverye
< 30 years 406 1 20 1.20 (0.77–1.89) 4 1.62 (0.60–4.33)
³ 30 years 876 1 41 1.00 (0.73–1.37) 16 2.22 (1.35–3.64)
Previous6 preterm birthf
or stillbirthg
No 1265 1 58 1.06 (0.82–1.38) 18 1.97 (1.24–3.14)
Yes 17 1 3 1.02 (0.30–3.49) 2 3.64 (0.84–15.8)
aAdjusted for age of the woman, calendar period, parity and age at first birth. bTest for effect modification: P = 0.47. A similar lack of effect modification
(P = 0.73) was found if age of woman was divided by age 50 years. c‘Previous’ means prior to the most recent pregnancy. dTest for effect modification: P = 0.86.
eTest for effect modification: P = 0.67. fPre-term birth: gestational age < 37 weeks. gTest for effect modification: P = 0.76.having a delivery less than 32 gestational weeks and other women
increased from 1.72 to 1.73.
DISCUSSION
Based on this large cohort of almost half a million parous women
we found reassuring evidence that a preterm delivery of 32+
weeks’ gestation does not significantly increase the risk of
premenopausal breast cancer. Overall, 84% of all preterm deliv-
eries are of 32+ weeks’ gestation. Only for the small group of
preterm deliveries of less than 32 weeks’ gestation was there a
twofold increased risk of breast cancer when comparing with a full-
term delivery. This elevated relative risk was obtained in an
analysis in which a woman’s person-years at risk were calculated
continuously according to the gestational age of the most recent
birth. In an analysis that compared parous women ever having a
delivery of less than 32 gestational weeks with other parous women
the risk was 1.7-fold increased. In this last analysis, the preterm
birth will not necessarily have been the most recent birth, and we
speculate whether the somewhat lower estimate could indicate that
a full-term birth following a preterm birth might diminish the effect
of a preterm birth on breast cancer risk. We found some support for
this assumption in a restricted analysis that estimated the risk in
parous women ever having a delivery of less than 32 weeks’ gesta-
tion but with the most recent delivery being of 32+ gestational
weeks. However, this particular analysis has very limited power.
The analysis of parous women ever having a delivery with a
gestational age less than 32 weeks compared with other women
might be subject to some misclassification, since many of the
included women may have had preterm births prior to 1978. This
misclassification, however, is non-differential, and estimating the
effect, we found we could ignore it, as only a very small fraction of
women categorized as never having a delivery with a gestational
age less than 32 weeks in fact had such a birth prior to 1978.
We used a cohort design for our study based on mandatory
reported exposure and outcome information. Nonetheless, some
limitations of the study should be acknowledged. Our gestational
age-specific RR estimates do not follow a smooth curve, but
instead increase rather abruptly below 32 weeks’ gestation. This
might suggest that the elevated risk of breast cancer among
women with a very early preterm delivery was a chance finding.
However, another explanation would be that the small number of
cases with very early preterm deliveries makes it difficult to assess
the true magnitude of the effect. In particular, the estimate
obtained among women with a preterm delivery of less than
29 weeks was based on only seven cases of breast cancer and 9000
person-years of follow-up. That said, it is important to note that
this estimate did not stand alone but was supported by a similarly
increased risk for women with a preterm delivery of 29–31 gesta-
tional weeks. We were unable to determine whether the observed
risk was due to the preterm delivery per se or the shorter duration
of pregnancy. The observation that both women with a preterm
stillbirth and women with a preterm livebirth (< 32 weeks) had
elevated RR of breast cancer would be in support of the latter but
these were very few.
The present study allowed us to consider the influence of poten-
tially confounding factors such as age, age at first birth, parity,
multiple births, abortion history and history of stillbirths.
However, several factors (smoking history, body mass index, age
at menarche and menopause, family history, oral contraceptives,
postmenopausal hormones) that have been suspected as risk
factors for breast cancer could not be adjusted for because we
lacked the necessary information. The lack of adjustment for such
factors would only be important for our results should these
factors influence both the occurrence of breast cancer and preterm
births. Smoking during pregnancy and high pre-pregnant body
weight have been linked to preterm births (Naeye, 1990; Williams
et al, 1992). However, there is little evidence for an association
between smoking and breast cancer (Palmer and Rosenberg, 1993)
and the association between high body mass and premenopausal
breast cancer is, if anything, inverse (Hunter and Willett, 1993).
Other factors that have been associated with preterm births are low
social class and low educational level (Pickering and Deeks,
1991). However, breast cancer risk is associated with high social
status and thus we would expect the observed relative risks to be
underestimated, rather than the opposite.
We are not aware of any previous cohort study addressing the
risk of breast cancer according to week of gestation at delivery. In a
case-control study, Choi et al (1978) reported an insignificantly
1.4-fold increased risk of breast cancer in premenopausal women
who had a terminated pregnancy of more than 5 gestational months
compared to women without such experience. Another case-control
study focusing on livebirths, with seven women with a delivery of
less than 30 weeks, did not find an increased risk among women
with preterm deliveries (Polednak and Janerich, 1983). Stillbirth
has not been associated with increased risk of breast cancer, but the
available studies have been based on a very limited number of
cases and lacked information on gestational length of the preg-
nancy (Brimton et al, 1983; Rao et al, 1994; Calle et al, 1995).
Studies of spontaneous abortion have generally not revealed
significantly positive associations (reviewed in Calle et al, 1995).
In a recent study by Newcomb et al (1996), a slightly increased
risk of breast cancer was recorded, but the authors cautioned that
the finding might be due to recall bias in their case-control design.
Most spontaneous abortions take place early in pregnancy and
studies have so far lacked detailed information on gestational
week at the time of the abortion. Spontaneous abortion may in
certain ways be more like a preterm delivery than an induced abor-
tion but they both represent an interruption of pregnancy (Zang,
1996). The results of case-control studies on induced abortion
have been inconsistent with risk estimates ranging from moder-
ately elevated to lowered values (Rosenberg et al, 1994). In a large
prospective study we found no overall increased risk of breast
cancer after an induced abortion, with the exception of the very
small group of women with a late second trimester abortion
(Melbye et al, 1997).
In conclusion, a preterm delivery did not significantly increase a
woman’s risk of contracting premenopausal breast cancer, apart
from the very small group of women with a preterm delivery of
less than 32 weeks’ gestation. Despite the large size of this study
there were only a few cases of breast cancer in the subgroups
representing the very early deliveries and these results should
therefore be considered with due caution.
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